Ivermectin Lotion, 0.5% + SKLICE (ivermectin) Lotion, 0.5% + Vehicle of the Test product
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Lice; Head Lice
Conditions
Lice; Head Lice
Trial Timeline
Mar 20, 2017 → Aug 18, 2017
NCT ID
NCT03257943About Ivermectin Lotion, 0.5% + SKLICE (ivermectin) Lotion, 0.5% + Vehicle of the Test product
Ivermectin Lotion, 0.5% + SKLICE (ivermectin) Lotion, 0.5% + Vehicle of the Test product is a phase 1 stage product being developed by Sun Pharmaceutical for Lice; Head Lice. The current trial status is completed. This product is registered under clinical trial identifier NCT03257943. Target conditions include Lice; Head Lice.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03257943 | Phase 1 | Completed |
Competing Products
11 competing products in Lice; Head Lice
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| MALG + Ovide (malathion) lotion 0.05% + Permethrin 1% | Sun Pharmaceutical | Phase 3 | 77 |
| MALG | Sun Pharmaceutical | Phase 2 | 52 |
| ivermectin + malathion | Johnson & Johnson | Phase 3 | 77 |
| Abametapir Lotion 0.74% w/w + Vehicle Lotion | Dr. Reddy's Laboratories | Phase 3 | 74 |
| Ha44 Gel 0.74% w/w | Dr. Reddy's Laboratories | Phase 2 | 49 |
| Abametapir Lotion 0.74% w/w + Vehicle Lotion | Dr. Reddy's Laboratories | Phase 3 | 74 |
| Abametapir Lotion 0.74% w/w | Dr. Reddy's Laboratories | Phase 1 | 30 |
| Abametapir Lotion 0.74% w/w + Sodium Lauryl Sulfate + Saline 0.9% + Placebo | Dr. Reddy's Laboratories | Phase 1 | 30 |
| Abametapir Lotion 0.74% w/w + Vehicle Lotion | Dr. Reddy's Laboratories | Phase 2 | 49 |
| Ha44 Gel | Dr. Reddy's Laboratories | Phase 2 | 49 |
| Ivermectin 0.5% Topical Application Lotion + Ivermectin 0.5% Topical Application Lotion [SKLICE] + Placebo 0% Lotion | Mayne Pharma Group | Phase 3 | 69 |
Other Products from Sun Pharmaceutical
Ilumya Injectable ProductApproved
85
CequaTM (Cyclosporine 0.09%) ophthalmic solutionApproved
85
Cyclosporine + Artificial tearApproved
85
AmifostineApproved
85
Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapyApproved
85